Hancock Mark sold $8.6M of PACS
Hancock Mark (Co Fndr; Exec V Chair) sold 236,320 shares of PACS Group, Inc. (PACS) at an average of $36.18 ($35.90–$37.88, $8.55M total) across 4 trades over 2026-06-15 to 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete, dated insider selling event (236,320 shares; ~$8.55M) but is mitigated by the stated use of a Rule 10b5-1 pre-arranged plan.
Market read
Traders may monitor for follow-on insider activity, but this specific filing alone is unlikely to drive a major repricing without additional catalysts.
What to watch
The filing does not disclose reasons for sale, and the net effect depends on whether there are offsetting insider buys or other contemporaneous fundamental updates.
Background
The article is an SEC EDGAR Form 4 insider transaction for PACS Group, Inc., reporting an open-market sale by an executive/director/10% owner.
Ticker impact
PACS Group disclosed via SEC Form 4 that Hancock Mark (Exec V Chair, 10% owner) sold 236,320 shares for ~$8.55M under a 10b5-1 plan.
Likely limited near-term impact; any reaction should be small unless accompanied by other company-specific catalysts.
The filing is primary-source and time-stamped, but it is an open-market sale executed under a pre-arranged 10b5-1 plan, which typically dampens inference about near-term fundamentals.
Market effects
No sector-wide read-through; this is a single-company insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sales were executed under a pre-arranged 10b5-1 plan, the transaction may reflect liquidity/portfolio management rather than a bearish view.
Key entities
- issuerPACS Group, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderHancock Mark
Exec V Chair; officer/director/10% owner who sold shares under a 10b5-1 plan.
